Home Search

combigene - search results

If you're not happy with the results, please do another search
Companypresentations_BIM2023Sept

Watch the presentations from BioStock Investor Meeting!

CombiGene welcomes AmbioPharm as CDMO in pain project

CombiGene welcomes AmbioPharm as CDMO in pain project

CombiGene's new CEO talks about his visions for the company

CombiGene’s new CEO talks about his visions for the company

CombiGene Q2 highlights and insights

CombiGene’s CEO gives a status update

CombiGene's CEO on the participation at BIO2023 in Boston

CombiGene’s CEO on the participation at BIO2023 in Boston

Aptahem's CEO comments on Q2 and looks ahead

Prominent role for CombiGene in newly established national ATMP collaboration

Zyneyro's CEO on the collaboration with CombiGene

Zyneyro’s CEO on the collaboration with CombiGene

CombiGenes vd Jan Nilsson i BioStocks tv-studio i Sotckholm

Status update from CombiGene’s CEO

CombiGene-epilepsi

Article about CombiGene’s epilepsy project published in Gene Therapy

CombiGene

CombiGene’s pain project receives new scientific support

BioStock Life Science Summit 2023

Jan Nilsson, vd CombiGene

CombiGene´s CEO provides an operational update

BioStock Investor Meeting Stockholm

BioStock Investor Meeting September 20

Chronic pain in focus for CombiGene´s new collaboration

genterapi vid allvarlig hudsjukdom

Progress with a new gene therapy in severe skin disease

Combigene FDA approval Hemgenix

CombiGene’s CEO on the FDA approval of Hemgenix

CombiGene Q3 2022

CombiGene’s CEO on the favourable position

CombiGene

CombiGene’s new COO wants to be involved in building a large...

CombiGene focuses on further in-licensing

EU gene therapy approval positive for CombiGene

BioMarin’s gene therapy treatment receives EU approval

CombiGene comments on positive news for Bluebird

Cominie

CombiGene’s new project manager on a broadened pipeline

CombiGene

CombiGene’s Chairman of the Board comments on the future

CombiGene strives for a broader pipeline

CombiGene strives for a broader pipeline

CombiGene’s CEO gives business development update

CombiGene

CombiGene sails with tailwinds

CombiGene’s CEO about the path to the first clinical trial

CombiGene

CombiGene gears up for clinical studies and expanded pipeline

CombiGene are looking for broader opportunities

CombiGene’s scientific founders on the agreement with Spark

CombiGene strikes deal with Spark Therapeutics

CombiGene comments the international patent application

CombiGene’s CEO on this summer’s news

CombiGene gears up in epilepsy project

CombiGene’s new Chairman on visions for the future

CombiGene’s new agreement important for future clinical studies

CombiGene one step closer to clinical trials

Aptahem’s founder is back – now as Chairman of the Board

Bayer acquires gene therapy company AskBio in billion-dollar deal

CombiGene comments the final preclinical steps

CombiGene om den första in vivo-studien i lipodystrofiprojektet CGT2

CombiGene signs agreement and insiders buy shares

CombiGene comments on their latest progress

Interview with CombiGene’s new CMC expert

CombiGene headhunts again

CombiGene raised 75MSEK through rights issue

CombiGene announces several milestones for CG01

CombiGene paved the way for 2022 during 2020

CombiGene advances preclinically and recruits post-doc

CombiGene is preparing for the clinic

CombiGene on the International Epilepsy Day and the pharmaceutical authorities’ positive...

Status report CombiGene – In the front line of gene therapy

© BioStock 2023